Kinetic model of acetate metabolism in healthy and hyperinsulinaemic humans

European Journal of Clinical Nutrition

Volumn 68, Issue 9, 2014, Pages 1067-1071

  Fernandes, J ^a   Vogt, J ^a   Wolever, T M S ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; CHOLESTEROL; FATTY ACID ACETATE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ACETIC ACID DERIVATIVE;

ABSORPTION; ACETATE ABSORPTION; ACETATE METABOLISM; ARTICLE; BODY MASS; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DESCENDING COLON; HEPATIC UPTAKE; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; KINETICS; LIPID METABOLISM; METABOLISM; ORAL GLUCOSE TOLERANCE TEST; SYSTOLIC BLOOD PRESSURE; TRANSPORT KINETICS; WAIST CIRCUMFERENCE; ADULT; BLOOD; COLON; FEMALE; HYPERINSULINISM; INSULIN RESISTANCE; INTESTINE ABSORPTION; LIVER; MALE; REFERENCE VALUE;

ACETATES; ADULT; COLON; FEMALE; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; INTESTINAL ABSORPTION; LIVER; MALE; REFERENCE VALUES;

EID: 84929046560     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2014.136     Document Type: Article

References (34)

1. Sluijs I, van der Schouw YT, van der A DL, Spijkerman AM, Hu FB, Grobbee DE et al. Carbohydrate quantity and quality and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition-Netherlands (EPIC-NL) study. Am J Clin Nutr 2010; 92: 905-911.
2. Anderson JW, Baird P, Davis RH Jr, Ferreri S, Knudtson M, Koraym A et al. Health benefits of dietary fiber. Nutr Rev 2009; 67: 88-205.
3. deMunter JSL, Hu FB, Spiegelman D, Franz M, van Dam RM. Whole grain bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med 2007; 4: 1385-1394.
4. Montonen J, Knekt P, Jarvinen R, Aromaa A, Reunanen A. Whole-grain and fiber intake and the incidence of type 2 diabetes. Am J Clin Nutr 2003; 77: 622-629.
5. Isken F, Klaus S, Osterhoff M, Pfeiffer AF, Weickert MO. Effects of long-term soluble vs insoluble dietary fiber intake on high-fat diet-induced obesity in C57BL/6 J mice. J Nutr Biochem 2010; 21: 278-284.
6. Weickert MO, Mohlig M, Schofl C, Arafat AM, Otto B, Viehoff H et al. Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care 2006; 29: 775-780.
7. Weickert MO, Mohlig M, Koebnick C, Holst JJ, Namsolleck P, Ristow M et al. 2005. Impact of cereal fibre on glucose-regulating factors. Diabetologia 2005; 48: 2343-2353.
8. Hoverstad T, Bohmer T, Fausa O. Absorption of short-chain fatty acids from the human colon measured by the 'CO2 breath test. Scand J Gastroenterol 1982; 17: 373-378.
9. Ruppin H, Bar-Meir S, Soergel KH, Wood CM, Schmitt MG. Absorption of short-chain fatty acids by the colon. Gastroenterology 1980; 78: 1500-1507.
10. McNeil NI, Cummings JH, James WPT. Short-chain fatty acid absorption by the human large intestine. Gut 1978; 19: 19-22.
11. Cummings JH, Branch WJ. Fermentation and the production of short-chain fatty acids in the human large intestine. In: Vahouny GV., Kritchevsky D (eds) Dietary fiber: basic and clinical aspects. Plenum Press: New York, USA, 1986, pp 131-149.
12. Wolever TMS, Spadafora P, Eshuis H. Interaction between colonic acetate and propionate in humans. Am J Clin Nutr 1991; 53: 681-687.
13. Fernandes J, Vogt J, Wolever TMS. Intravenous acetate elicits a greater free fatty acid rebound in normal than hyperinsulinaemic humans. Eur J Clin Nutr 2012; 66: 1029-1034.
14. Fernandes J, Vogt J, Wolever TMS. Inulin increases short-term markers for colonic fermentation similarly in healthy and hyperinsulinaemic humans. Eur J Clin Nutr 2011; 65: 1279-1286.
15. Vogt JA, Wolever TMS. Fecal acetate is inversely related to acetate absorption from the human rectum and distal colon. J Nutr 2003; 133: 3145-3148.
16. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 2000; 23: 171-175.
17. Tollinger CD, Vreman HJ, Wiener MW. Measurement of acetate in human blood by gas chromatography: effects of sample preparation, feeding and various diseases. Clin Chem 1991; 53: 681-687.
18. Wolever TMS, Brighenti F, Jenkins DJA. Serum short chain fatty acids after rectal infusion of acetate and propionate in man. J Clin Nutr Gastroenterol 1988; 3: 42-46.
19. Skutches CL, Holroyde CP, Myers RN, Paul P, Reichard GA. Plasma acetate turnover and oxidation. J Clin Invest 1979; 64: 708-713.
20. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1131.
21. Sheppach W, Pomare EW, Elia M, Cummings JH. The contribution of the large intestine to blood acetate in man. Clin Sci 1991; 80: 177-182.
22. Snoswell AM, Trimble RP, Fishlock RC, Storer GB, Topping DL. Metabolic effects of acetate in perfused rat liver: studies on ketogenesis, glucose output, lactate uptake and lipogenesis. Biochim Biophys Acta 1982; 716: 290-297.
23. Buckley BM, Williamson DH. Origin of blood acetate in the rat. Biochem J 1977; 166: 539-545.
24. Seufert CD, Graf M, Janson G, Kuhn A, Söling HD. Formation of free acetate by isolated perfused livers from normal, starved and diabetic rats. Biochem Biophys Res Commun 1974; 57: 901-909.
25. Lundquist F, Sestoft L, Damgaard SE, Clausen JP, Trap-Jensen J. Utilization of acetate in the human forearm during exercise after ethanol ingestion. J Clin Invest 1973; 52: 3231-3235.
26. Layden BT, Yalamanchi SK, Wolever TM, Dunaif A, Lowe WL Jr. Negative association of acetate with visceral adipose tissue and insulin levels. Diabetes Metab Syndr Obes 2012; 5: 49-55.
27. Piloquet H, Ferchaud-Roucher V, Duengler F, Zair Y, Maugere P, Krempf M. Insulin effects on acetate metabolism. Am J Physiol Endocrinol Metab 2003; 285: E561-E565.
28. Quin J, Li Y, Cai Z, Li S, Zhu J, Zhang F et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490: 55-60.
29. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK et al. Gut microbiota in human adults with type 2 diabetes differs from nondiabetic adults. PLoS One 2010; 5: e9085.
30. Wu X, Ma C, Han L, Nawaz M, Gao F, Zhang X et al. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol 2010; 61: 69-78.
31. Esteve E, Ricart W, Fernández-Real JM. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance? Curr Opin Clin Nutr Metab Care 2011; 14: 483-490.
32. De Bandt JP, Waligora-Dupriet AJ, Butel MJ. Intestinal microbiota in inflammation and insulin resistance: relevance to humans. Curr Opin Clin Nutr Metab Care 2011; 14: 334-340.
33. Diamant M, Blaak EE, de Vos WM. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?. Obes Rev 2011; 12: 272-281.
34. Rahat-Rozenbloom S, Fernandes J, Gloor GB, Wolever TMS. Evidence for greater production of colonic short-chain fatty acids in overweight than lean humans. Int J Obesity 2014; e-pub ahead of print 19 March 2014; doi:10.1038/ijo.2014.46.